The purpose of this study is to determine whether Zolpidem and Zoplicone are efective in the treatment of sleep disorders in Alzheimer's disease (AD)
Sleep disorders (SD) affects 35 to 50 percent of patients with AD. These disorders often make caring for patients at home very difficult. Zolpidem and Zoplicone are prescribed drugs for sleep disorder in AD patients.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
62
Geriatric Medical Centre
Brasília, Federal District, Brazil
Nighttime Total Sleep Time
Mean Total Sleep Time (in minutes) during the 12h nocturnal period (8:00pm-8:00am) after 2 weeks under treatment
Time frame: Baseline, 14 days follow-up
Daytime Total Sleep Time
Daytime Total Sleep Time (in minutes) during the 12h daytime period (8:00am-8:00pm) after 2 weeks under treatment
Time frame: Baseline, 14 days follow-up
Ratio of daytime to nighttime sleep
Daytime Total Sleep Time / Nighttime Total Sleep Time
Time frame: Baseline, 14 days follow-up
Nighttime Wake after Sleep Onset
Nighttime Wake after Sleep Onset (in minutes) during the 12h nocturnal period (8:00pm-8:00am) after 2 weeks under treatment
Time frame: Baseline, 14 days follow-up
Proportion of sleep time at nighttime
Proportion of sleep time (%) during the 12h nocturnal period (8:00pm-8:00am) after 2 weeks under treatment
Time frame: Baseline, 14 days follow-up
Proportion of patients with gain of at least 30 minutes in Total Sleep Time
Proportion of patients with gain of at least 30 minutes in Total Sleep Time after 2 weeks under treatment
Time frame: Baseline, 14 days follow-up
Differences between sleep efficiency between the two treatments.
Analyze possible differences between sleep efficiency between the two treatments after 2 weeks under treatment
Time frame: Baseline, 14 days follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Nighttime Number of Awakenings
Change in scores of nighttime number of awakenings from baseline to intervention weeks
Time frame: Baseline, 14 days follow-up